Corrigendum: Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.

Front Pharmacol

Department of Basic Sciences, School of Dentistry, São Paulo State University (UNESP), Araçatuba, Brazil.

Published: February 2021

[This corrects the article DOI: 10.3389/fphar.2020.579926.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934963	PMC
http://dx.doi.org/10.3389/fphar.2020.635927	DOI Listing

Publication Analysis

corrigendum telmisartan

telmisartan prevents

prevents alveolar

alveolar bone

bone loss

loss decreasing

decreasing expression

expression osteoclasts

osteoclasts markers

markers hypertensive

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!